Production (Stage)
KORU Medical Systems, Inc.
KRMD
$2.66
-$0.06-2.21%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 9.01% | 8.05% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 9.01% | 8.05% | |||
| Cost of Revenue | 9.55% | 9.41% | |||
| Gross Profit | 8.69% | 7.27% | |||
| SG&A Expenses | 2.28% | 13.63% | |||
| Depreciation & Amortization | 2.79% | -7.16% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 4.33% | 5.51% | |||
| Operating Income | 21.67% | 6.68% | |||
| Income Before Tax | 25.16% | 1.42% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 25.30% | 1.25% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 25.30% | 1.25% | |||
| EBIT | 21.67% | 6.68% | |||
| EBITDA | 31.20% | -1.23% | |||
| EPS Basic | 25.51% | 1.16% | |||
| Normalized Basic EPS | 24.29% | 2.33% | |||
| EPS Diluted | 25.51% | 1.16% | |||
| Normalized Diluted EPS | 24.29% | 2.33% | |||
| Average Basic Shares Outstanding | 0.32% | -0.03% | |||
| Average Diluted Shares Outstanding | 0.32% | -0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||